Baillie Gifford - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$302,869,587
-30.9%
14,681,027
-1.1%
0.28%
-25.8%
Q2 2023$438,039,653
+23.8%
14,843,770
-3.3%
0.37%
+16.6%
Q1 2023$353,712,637
-15.9%
15,352,111
+1.5%
0.32%
-27.2%
Q4 2022$420,472,572
-6.9%
15,119,474
+2.7%
0.44%
-6.0%
Q3 2022$451,605,000
+3.2%
14,715,051
-1.0%
0.47%
+3.8%
Q2 2022$437,606,000
-9.2%
14,869,374
-0.7%
0.45%
+32.8%
Q1 2022$481,921,000
-28.2%
14,980,432
-0.5%
0.34%
-8.2%
Q4 2021$671,515,000
-11.3%
15,056,381
+0.3%
0.37%
-7.1%
Q3 2021$757,245,000
-36.3%
15,009,816
-0.9%
0.40%
-31.6%
Q2 2021$1,188,179,000
+60.1%
15,147,613
+16.6%
0.58%
+39.5%
Q1 2021$742,026,000
-27.3%
12,995,197
+6.6%
0.42%
-26.9%
Q4 2020$1,021,056,000
+163.2%
12,190,256
+12.6%
0.57%
+112.7%
Q3 2020$387,938,000
+72.9%
10,827,178
+16.7%
0.27%
+56.1%
Q2 2020$224,371,000
+40.4%
9,279,194
+1.6%
0.17%
-1.2%
Q1 2020$159,861,000
+20.9%
9,129,752
+20.3%
0.17%
+35.2%
Q4 2019$132,221,000
+17.2%
7,590,247
+3.1%
0.13%0.0%
Q3 2019$112,809,000
-26.6%
7,363,463
-0.6%
0.13%
-21.5%
Q2 2019$153,773,000
+5.8%
7,407,229
+18.3%
0.16%
+2.5%
Q1 2019$145,408,000
+13.0%
6,262,226
+0.6%
0.16%
-4.8%
Q4 2018$128,665,000
+7.9%
6,227,724
+13.5%
0.17%
+29.5%
Q3 2018$119,275,000
+46.3%
5,486,421
+2.7%
0.13%
+46.6%
Q2 2018$81,506,000
-20.3%
5,344,633
+2.9%
0.09%
-26.7%
Q1 2018$102,247,000
+32.8%
5,192,846
+5.5%
0.12%
+25.0%
Q4 2017$76,976,0004,921,7830.10%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders